We invite you to read the sources below to learn more about CAR T-cell therapy for lymphoma. 

News articles and pages

• FDA Determines CAR-T Can Be Safely Given Without Risk Evaluation and Mitigation Strategies (REMS)
• New Way to Engineer CAR T-Cells Could Make it More Accessible
• Is CAR T-cell Therapy More Effective for Transformed Follicular Lymphoma or De Novo DLBCL?
• Can Mental Health Conditions Impact CAR T-Cell Therapy for LBCL Patients?
• CAR-T therapy and secondary hematological malignancies
• Is Odronextamab Effective if CAR-T Stops Working for DLBCL?
• Real World Outcomes of Liso-cel for Large B-cell Lymphoma
• How Effective is Tab-cel for EBV+ Post-Transplant Lymphoma?
• New CAR-T Therapy Targets CD22 to Treat Follicular and Mantle Cell Lymphoma
• How Does Axi-cel Perform in the Real World for People with LBCL?
• If CAR T-Cell Therapy Fails, How Effective Are Bispecific Antibodies for Large B-Cell Lymphoma?
• Studying the Keto Diet's Impact on CAR T-Cells for Large B-Cell Lymphoma
• Understanding How CAR T Works in the Real World for Follicular Lymphoma
• Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients
• CAR T-Cell Therapy: Long-Term Side Effects and Patient Outcomes from ASH 2024
• Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy
• Factors That Can Influence How Well CAR T-Cell Therapy Works for MCL
• Azer-cel, a New CAR T-Cell Therapy for DLBCL
• Is it Safe for R/R DLBCL Patients to Receive CAR T-cell Therapy in an Outpatient Setting?
• How One DLBCL Therapy Is Proving Its Worth: Three Years Later
• New Clinical Trial with Armored CAR T-cells
• Making CAR-T Therapy Safer and More Accessible for DLBCL Patients
• What If My CAR-T Fails?
• EHA 2024: Can Patients Over 75 Be Treated with CAR T-cell Therapy?
• New CAR T-Cell Therapy Approved for MCL
• CAR T-Cell Therapy Advances in Large B Cell Lymphoma
• Liso-cel CAR T-Cell Therapy Receives FDA Approval for Follicular Lymphoma
• Factors that Influence Blood Transfusion Needs for DLBCL Patients Receiving CAR T-Cell Therapy
• CAR T-cell Therapy for Follicular Lymphoma
• A Deep Dive into CAR T-Cell vs. Bispecific Antibodies for Relapsed or Refractory DLBCL
• Predicting Drug Toxicity in CAR T-Cell Therapy Recipients
• Trial of an Education Video to Help CAR-T Cell Therapy Recipients
• MSKCC’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants 
• What is CAR T-Cell Therapy?
• HealthTree Celebrates the Accomplishments of Carl June, Father of CAR-T

HealthTree University (HTU) videos

• Lymphoma CAR-T UNIT
• What is CAR-T cell therapy and how is this drug class used to treat follicular lymphoma?
• Optimizing Monitoring After CAR-T Therapy 

Events recordings 

• The Future of Lymphoma Treatment: What's in the Research Pipeline?
• Early-Stage Research: Exploring the Science Behind a Keto Diet and CAR T Therapy in Lymphoma
• From First-Line to Third and Beyond: What to Expect for LBCL Treatments
• Changing Course: Treatment Options for Lymphoma Relapse Following CAR-T Therapy
• CAR-T Therapy for Lymphoma: Barriers and Solutions to Access
• TRANSCEND FL Trial Updates with Dr. Manali Kamdar
• Latest Advancements in CAR T-cell Therapy with Dr. Ehsan Malek
• CAR T-cell Therapy and Stem cell transplant in Lymphoma patients: Current treatment landscape
• From Trial to Triumph: Robyn's Pioneering CAR T-cell Therapy Journey
• CAR T-Cell Therapy Advances in Large B-Cell Lymphoma
• Treatment Options for Relapsed/Refractory DLBCL with Dr. Elif Yilmaz